Position in RNA
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,523,589
New position
Shares Held
113,278
first reported quarter
Ownership
0.662%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#1
of 20 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trium Capital LLP holds $12,505,730 across 2 Biotechnology names. RNA ranks #2 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALMS |
Alumis Inc.
|
390,268 | $10,982,141 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
This page
|
113,278 | $1,523,589 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,523,589 | 113,278 | Shares | Sole | 2026-07-16 | |
| No filing history on record for this holder in this stock. | ||||||